Showing results (1-10 of 210) with videos related to

Sort By:
Pageof 21
Frontiers in Cellular Neuroscience|March 1, 2013
What does a mouse tell us about neuregulin 1-cannabis interactions?Tim Karl, Jonathon C Arnold
Expert Opinion on Therapeutic Targets|March 28, 2012
The therapeutic potential of the endocannabinoid system for Alzheimer's diseaseTim Karl, David Cheng, Brett Garner, et al.
Psychopharmacology|June 24, 2010
A follow-up study: acute behavioural effects of Delta(9)-THC in female heterozygous neuregulin 1 transmembrane domain mutant miceLeonora E Long, Rose Chesworth, Jonathon C Arnold, et al.
The International Journal of Neuropsychopharmacology|September 30, 2009
A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc miceLeonora E Long, Rose Chesworth, Xu-Feng Huang, et al.
The International Journal of Neuropsychopharmacology|January 10, 2012
Transmembrane domain Nrg1 mutant mice show altered susceptibility to the neurobehavioural actions of repeated THC exposure in adolescenceLeonora E Long, Rose Chesworth, Xu-Feng Huang, et al.
Pharmacology, Biochemistry, and Behavior|June 1, 2005
The role of endocannabinoid transmission in cocaine addictionJonathon C Arnold
Australian Journal of General Practice|June 1, 2021
A primer on medicinal cannabis safety and potential adverse effectsJonathon C Arnold
The International Journal of Neuropsychopharmacology|August 13, 2010
The schizophrenia susceptibility gene neuregulin 1 modulates tolerance to the effects of cannabinoidsAurélie A Boucher, Glenn E Hunt, Jacques Micheau, et al.
Psychopharmacology|April 14, 2025
Behavioural effects of oral cannabidiol (CBD) treatment in the superoxide dismutase 1 G93 A (SOD1<sup>G93 A</sup>) mouse model of amyotrophic lateral sclerosisSandip Ghimire, Fabian Kreilaus, Rossana Rosa Porto, et al.
Plos One|April 18, 2012
Distinct neurobehavioural effects of cannabidiol in transmembrane domain neuregulin 1 mutant miceLeonora E Long, Rose Chesworth, Xu-Feng Huang, et al.
Pageof 21